五洲医疗 - Financials

五洲医疗 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017
+Revenue	477.0M	534.0M	547.0M	513.0M	471.0M	487.0M	436.0M	360.0M
Revenue Growth %	-10.7%	-2.4%	6.6%	8.9%	-3.3%	11.7%	21.1%	--
Total Revenue	477.0M	534.0M	547.0M	513.0M	471.0M	487.0M	436.0M	360.0M
Cost Of Revenue	392.0M	420.0M	424.0M	397.0M	375.0M	379.0M	351.0M	272.0M
+Gross Profit	85.0M	114.0M	123.0M	116.0M	96.0M	108.0M	85.0M	88.0M
Gross Margin %	17.8%	21.3%	22.5%	22.6%	20.4%	22.2%	19.5%	24.4%
Total Operating Cost	438.0M	470.0M	485.0M	439.0M	417.0M	428.0M	398.0M	337.0M
Selling Expenses	14.1M	15.3M	13.1M	7.2M	5.9M	22.4M	21.6M	18.5M
Admin Expenses	19.0M	19.9M	30.2M	12.7M	13.2M	12.6M	11.4M	24.3M
Rd Expenses	13.0M	13.5M	13.1M	11.8M	10.0M	9.9M	9.1M	8.3M
Finance Expenses	-9.0M	-8.0M	-7.9M	4.1M	9.4M	159,500	-1.2M	7.3M
+Operating Income	46.9M	68.5M	62.1M	80.1M	69.0M	64.1M	41.6M	32.3M
Operating Margin %	9.8%	12.8%	11.3%	15.6%	14.6%	13.2%	9.5%	9.0%
Non Operating Income	140,400	3.4M	14.0M	30,200	19,700	343,500	67,100	67,100
Non Operating Expenses	616,700	950,400	2.6M	243,400	399,000	301,600	147,200	2.5M
Investment Income	1.8M	3.6M	-7.7M	2.1M	1.7M	-2.3M	-240,900	--
Fair Value Change Income	895,100	-1.3M	1.6M	--	7.2M	-1.3M	-30,600	--
Asset Disposal Income	14,200	--	--	-472,900	--	--	-1.9M	-939,000
Asset Impairment Loss	3.1M	2.7M	4.3M	2.5M	1.1M	448,400	3.2M	2.6M
Other Income	4.9M	2.5M	6.1M	4.4M	5.7M	9.1M	5.5M	9.7M
Income Before Tax	46.5M	70.9M	73.4M	79.8M	68.6M	64.1M	41.5M	29.8M
Income Tax	6.5M	10.7M	2.5M	11.4M	11.9M	11.2M	7.7M	8.2M
+Net Income	40.0M	60.3M	70.9M	68.4M	56.7M	52.9M	33.8M	21.6M
Net Margin %	8.4%	11.3%	13.0%	13.3%	12.0%	10.9%	7.7%	6.0%
Net Income Attributable	40.0M	60.3M	70.9M	68.4M	56.7M	52.9M	33.8M	21.6M
Eps Basic	0.59	0.89	1.19	1.34	1.11	1.04	0.66	0.42
Eps Diluted	0.59	0.89	1.19	1.34	1.11	1.04	0.66	0.42

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017
Cash And Equivalents	156.0M	271.0M	104.0M	43.3M	49.3M	67.0M	20.5M	42.7M
Trading Financial Assets	221.0M	75.2M	261.0M	--	5.8M	237,700	--	--
Accounts Receivable	108.0M	92.7M	93.0M	90.2M	75.2M	80.0M	101.0M	52.0M
Notes Receivable	1.3M	782,100	241,000	--	--	--	--	--
Notes And Accounts Receivable	110.0M	93.5M	93.2M	90.2M	75.2M	80.0M	101.0M	52.0M
Prepayments	2.0M	2.1M	2.8M	10.8M	5.6M	1.4M	2.5M	709,300
Inventory	44.8M	47.2M	51.5M	51.6M	45.9M	35.3M	36.0M	32.4M
Total Current Assets	548.0M	508.0M	531.0M	206.0M	190.0M	198.0M	172.0M	143.0M
Fixed Assets	--	305.0M	169.0M	153.0M	116.0M	98.5M	92.0M	84.3M
Fixed Assets Total	301.0M	305.0M	169.0M	153.0M	116.0M	98.5M	92.0M	84.3M
Construction In Progress	--	21.8M	118.0M	8.8M	9.5M	10.1M	618,100	773,400
Construction In Progress Total	15.0M	21.8M	118.0M	8.8M	9.5M	10.1M	618,100	773,400
Intangible Assets	6.6M	7.2M	7.8M	8.4M	6.9M	7.2M	7.6M	7.8M
Long Term Deferred Expenses	54,600	64,200	99,100	184,900	--	--	--	--
Total Non Current Assets	325.0M	340.0M	314.0M	177.0M	137.0M	121.0M	108.0M	96.2M
Total Assets	873.0M	848.0M	845.0M	383.0M	327.0M	320.0M	280.0M	239.0M
Short Term Borrowings	--	--	--	12.8M	32.3M	34.0M	36.0M	36.5M
Accounts Payable	62.5M	60.5M	78.5M	65.0M	73.4M	83.4M	89.7M	75.6M
Advance Receipts	--	--	--	--	--	8.1M	6.0M	5.3M
Contract Liabilities	11.7M	11.1M	13.2M	17.2M	6.8M	--	--	--
Total Current Liabilities	93.3M	89.0M	109.0M	111.0M	123.0M	173.0M	147.0M	142.0M
Total Non Current Liabilities	16.9M	9.4M	12.4M	9.5M	9.6M	8.9M	6.8M	4.7M
Total Liabilities	110.0M	98.5M	121.0M	120.0M	133.0M	182.0M	154.0M	146.0M
Paid In Capital	68.0M	68.0M	68.0M	51.0M	51.0M	51.0M	51.0M	51.0M
Capital Reserve	395.0M	395.0M	395.0M	22.5M	22.5M	22.5M	22.5M	22.5M
Surplus Reserve	30.8M	27.9M	23.1M	17.5M	11.5M	7.8M	2.4M	728,900
Retained Earnings	268.0M	259.0M	237.0M	172.0M	109.0M	56.3M	50.8M	18.7M
Equity Attributable	762.0M	750.0M	723.0M	263.0M	194.0M	138.0M	127.0M	92.9M
Total Equity	762.0M	750.0M	723.0M	263.0M	194.0M	138.0M	127.0M	92.9M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017
Cash From Sales	468.0M	534.0M	550.0M	509.0M	471.0M	513.0M	389.0M	340.0M
Tax Refunds Received	43.7M	51.3M	55.1M	47.0M	51.6M	45.6M	57.6M	30.8M
Total Operating Cash Inflow	527.0M	592.0M	631.0M	561.0M	528.0M	570.0M	455.0M	385.0M
Cash Paid For Goods	337.0M	405.0M	406.0M	407.0M	389.0M	386.0M	351.0M	263.0M
Cash Paid To Employees	74.5M	73.6M	78.0M	61.5M	52.8M	52.1M	49.0M	40.0M
Taxes Paid	5.5M	8.7M	11.1M	12.4M	13.8M	16.0M	12.9M	13.7M
Total Operating Cash Outflow	438.0M	510.0M	520.0M	499.0M	473.0M	482.0M	439.0M	345.0M
Operating Cash Flow	88.9M	81.8M	111.0M	62.6M	55.0M	88.1M	15.8M	40.0M
Total Investing Cash Inflow	659.0M	664.0M	72.6M	9.8M	3.7M	400,000	--	7.0M
Total Investing Cash Outflow	839.0M	547.0M	504.0M	56.5M	33.7M	28.7M	25.9M	16.6M
Investing Cash Flow	-180.0M	117.0M	-431.0M	-46.7M	-30.0M	-28.3M	-25.9M	-9.6M
Cash From Borrowings	--	--	54.7M	32.4M	32.3M	67.0M	56.0M	64.0M
Dividends And Interest Paid	27.2M	34.0M	620,500	1.0M	36.1M	13.1M	12.3M	21.7M
Debt Repayments	--	--	67.5M	51.9M	34.0M	69.0M	56.5M	40.5M
Total Financing Cash Inflow	--	--	466.0M	32.4M	32.3M	67.0M	56.0M	64.0M
Total Financing Cash Outflow	27.9M	34.8M	87.6M	53.0M	70.0M	82.2M	68.7M	62.2M
Financing Cash Flow	-27.9M	-34.8M	378.0M	-20.5M	-37.8M	-15.2M	-12.7M	1.8M
Net Change In Cash	-115.0M	166.0M	60.9M	-5.6M	-16.0M	43.8M	-23.5M	30.3M
Ending Cash Balance	153.0M	268.0M	102.0M	41.4M	47.0M	63.0M	19.2M	42.7M
Capex	37.0M	70.9M	164.0M	56.5M	33.7M	23.6M	24.4M	16.6M